Canngea - Martin Bryden & Dr. Nial Wheate
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Canngea - Martin Bryden & Dr. Nial Wheate
-
Narrado por:
-
De:
Acerca de esta escucha
Martin Bryden and Dr. Nial Wheate join me from Canngea. We had a discussion about their business and what they are currently working on in the cannabis industry. We spoke on topics like the current state of the medical, nutraceutical, and recreational industries. Dr Nial Wheate broke down clinical trials and the bioavailability of cannabis.
To let you know Canngea is an Australian company that operates as a B2B Contract Manufacturing Organisation. They focus on Eu-GMP standards (Good Management Practices) and SOP’s (Standard Operating Procedures). Canngea can deliver consistent high-quality products at competitive rates.
They were established in Australia in September 2017. Canngea offers services to other companies in the medicinal cannabis industry to supply white label and private label solutions to produce products for wholesale in the domestic and international markets.